Upregulation of SATB1 is associated with the development and progression of glioma

Table 1 Correlations between SATB1 expression, clinicopathologic features and MGMT promoter methylation in 70 cases of glioma

Clinicopathologic variables	n	SATB1 expression		X ²	P-value
		Negative	Positive
All cases	70	26	44
Age (years)				1.004	0.446
<45	27	12	15
45	43	14	29
Gender				0.388	0.566
Male	54	19	35
Female	16	7	9
Tumor size (cm)				0.227	0.795
<3	24	8	16
3	46	18	28
Tumor locus				0.946	0.393
Supratentorial	53	18	35
Infratentorial	17	8	9
Pathological grade				6.119	0.025
Low grade I-II	35	18	17
High grade III-IV	35	8	27
MGMT promoter				25.150	0.000
Unmethylation	45	7	38
Methylation	25	19	6

ISSN: 1479-5876